Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
Explore this paper's citation graph
Summary
In chronic kidney disease patients with residual proteinuria despite combined angiotensin-converting enzyme inhibitor and angiotENSin receptor blockade therapy, add-on fluvastatin does not affect urinary proteins, but further reduces serum lipids and is safe.
- Type
- article
- Published
- 2010-11-01
- Cited by
- 50
- References
- 40
- Access
- Open access
- OpenAlex
- https://openalex.org/W20671225
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25219894
Keywords
Modal, Continuation, Computer science, Modal analysis, Rigid body
References
- Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
- Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers.
- Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
- Effects of fluvastatin slow-release (xl 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
- Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.
- Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
- Comparative Tolerability of the HMG-CoA Reductase Inhibitors
- Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.
- Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
- Albumin signals the coming of age of proteinuric nephropathy.
- Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
- Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
- Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies
- Role of remission clinics in the longitudinal treatment of CKD.
- Impact of Treatment of Dyslipidemia on Renal Function, Fat Deposits and Scarring in Patients with Persistent Nephrotic Syndrome
- An update on the lipid nephrotoxicity hypothesis
- Blood pressure-lowering effects of statins: who benefits?
- A multiple testing procedure for clinical trials.
Cited by
- The Remission Clinic approach to halt the progression of kidney disease.
- Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease.
- Off-target effects of RAAS-inhibition: importance on renal outcomes in patients with diabetes
- Novel drugs and intervention strategies for the treatment of chronic kidney disease
- Diabetes and kidney function
- Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis
- HMG-CoA Reductase Inhibitors in Chronic Kidney Disease
- Statins, inflammation and kidney disease
- Proteinuria should be used as a surrogate in CKD
- Statins in chronic kidney disease and kidney transplantation.
- Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence?
- Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes.
- Effects of Statins on Cardiorenal Syndrome
- Which antihypertensive drugs are the most nephroprotective and why?
- Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
- Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis.
- Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)
- Mechanisms and treatment of CKD.
- Renocardiac syndromes: physiopathology and treatment stratagems
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Related papers
- Flexible Bodies with COTS Control Design and Physical Modeling Tools
- Modal Analysis of Lumped Flexible Active Systems (Part 1)
- MODELING ISSUES FOR REAL-TIME PERFORMANCE IN FLEXIBLE MULTIBODY SYSTEMS
- Data-Driven Modeling of a Two-Link Flexible Manipulator (TLFM)
- Integrated Motion Measurement for Flexible Structures using a Modal and Krylov Subspace Model Reduction Approach
- Operational modal analysis via image based technique of very flexible space structures
- Identification and control of large flexible spacecraft
- Controlling flexible manipulators, an experimental investigation
- Experimental modal substructuring to estimate fixed-base modes from tests on a flexible fixture